Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Curr Protein Pept Sci ; 21(8): 772-776, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31724511

RESUMO

Dietary proteins are linked to the pathogenic Escherichia coli (E. coli) through the intestinal tract, which is the site where both dietary proteins are metabolized and pathogenic E. coli strains play a pathogenic role. Dietary proteins are degraded by enzymes in the intestine lumen and their metabolites are transferred into enterocytes to be further metabolized. Seven diarrheagenic E. coli pathotypes have been identified, and they damage the intestinal epithelium through physical injury and effector proteins, which lead to inhibit the digestibility and absorption of dietary proteins in the intestine tract. But the increased tryptophan (Trp) content in the feed, low-protein diet or milk fractions supplementation is effective in preventing and controlling infections by pathogenic E. coli in the intestine.


Assuntos
Diarreia/metabolismo , Proteínas Alimentares/metabolismo , Escherichia coli Enteropatogênica/metabolismo , Escherichia coli Enterotoxigênica/metabolismo , Infecções por Escherichia coli/metabolismo , Escherichia coli Shiga Toxigênica/metabolismo , Ração Animal/análise , Animais , Diarreia/dietoterapia , Diarreia/microbiologia , Diarreia/patologia , Dieta com Restrição de Proteínas/métodos , Proteínas Alimentares/uso terapêutico , Escherichia coli Enteropatogênica/efeitos dos fármacos , Escherichia coli Enteropatogênica/patogenicidade , Escherichia coli Enterotoxigênica/efeitos dos fármacos , Escherichia coli Enterotoxigênica/patogenicidade , Infecções por Escherichia coli/dietoterapia , Infecções por Escherichia coli/microbiologia , Infecções por Escherichia coli/patologia , Microbioma Gastrointestinal , Humanos , Absorção Intestinal/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiologia , Mucosa Intestinal/patologia , Proteínas do Leite/metabolismo , Proteínas do Leite/uso terapêutico , Escherichia coli Shiga Toxigênica/efeitos dos fármacos , Escherichia coli Shiga Toxigênica/patogenicidade , Triptofano/metabolismo , Triptofano/farmacologia
2.
Int J Clin Exp Med ; 8(10): 17151-66, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26770309

RESUMO

To compare the feasibility, efficiency and safety of coronary angiography (CAG) and interventional procedures between the radial and femoral catheterization approaches in Chinese population using systematic review and meta-analysis, we conducted a search of the studies comparing radial and femoral catheterization approaches in patients underwent either CAG or percutaneous coronary intervention (PCI) in Chinese population. Fixed-effect relative risk (RR) for the primary end points and the second end points were compared between the two approaches. A total of 27 studies (n=8,749 patients) were finally included in the analysis. The success rate of radial approach was slightly lower than that of femoral approach in patients receiving CAG (P=0.004), but similar in patients receiving a further PCI treatment (P=0.11). The risk of major adverse cardiovascular events (MACEs) was similar between two approaches (P=0.27). Radial catheterization had a significantly lower rate of puncture site complications (P<0.00001), but a lower rate of puncture success rate (P=0.02). In patients with acute myocardial infarction (AMI), there was no difference in neither the risk of MACEs nor PCI success rate between two approaches (P=0.23 and 0.45, respectively), but a board line decrease of puncture success rate was observed in radial catheterization group (P=0.04). There were no significant differences in the volumes of contrast media, X-ray exposure time and operation time between the two approaches (all P>0.05). Thus, we concluded that radial approach is a safe method for CAG or PCI compared to traditional femoral approach in Chinese population due to their similar success rate of the procedure and risk of MACEs, and a decreased risk of puncture site complications.

3.
Chinese Journal of Hepatology ; (12): 526-530, 2009.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-306653

RESUMO

<p><b>OBJECTIVE</b>To identify the metastasis-related miRNAs in hepatocellular carcinoma (HCC) cell lines.</p><p><b>METHODS</b>A qRT-PCR method was established and optimized.</p><p><b>RESULTS</b>All candidate metastasis associated miRNAs except miR-124a were expressed in high metastasis cell line MHCC97H and low metastasis cell line MHCC97L, while some miRNAs were differentially expressed between liver cancer cell line (HepG2) and hepatic cell line (L02) (P less than 0.05), these miRNAs include: miR-148b (1.96+/-0.51 vs 3.76+/-0.28), miR-9 (-4.38+/-0.86 vs -1.10+/-0.53), miR-30c (8.41+/-0.40 vs 6.82+/-0.29), miR-338 (3.14+/-0.29 vs -2.36+/-0.32), miR-34a (0.71+/-0.40 vs -2.95+/-0.26), Let-7g (-4.07+/-0.55 vs -6.98+/-0.56). miR-148b expression was about 4 times higher than miR-148a [5.46 (IQR 4.25-6.67) vs 1.29 (IQR 0.94-1.64)] in all cell line tested (Z=-5.097, P=3x10(-7)).</p><p><b>CONCLUSION</b>This study may help to understand the biological significance of miRNAs in HCC metastasis.</p>


Assuntos
Humanos , Carcinoma Hepatocelular , Genética , Metabolismo , Patologia , Linhagem Celular , Linhagem Celular Tumoral , DNA Complementar , Genética , Células Epiteliais , Metabolismo , Neoplasias Hepáticas , Genética , Metabolismo , Patologia , MicroRNAs , Genética , Metabolismo , Metástase Neoplásica , Reação em Cadeia da Polimerase
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...